Notice: This company has been marked as potentially delisted and may not be actively trading. AVROBIO (AVRO) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Get the Latest News and Ratings for AVRO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for AVROBIO and its competitors. Enter your email to sign up for newsletter Sign Up AVRO Analyst Ratings Over TimeTypeCurrent Forecast9/29/23 to 9/28/241 Month Ago8/30/23 to 8/29/243 Months Ago7/1/23 to 6/30/241 Year Ago9/29/22 to 9/29/23Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy0 Buy rating(s)0 Buy rating(s)0 Buy rating(s)2 Buy rating(s)Hold1 Hold rating(s)1 Hold rating(s)2 Hold rating(s)1 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$24.00$24.00$24.00$48.00Forecasted Upside1,614.29% Upside1,614.29% Upside1,614.29% Upside159.74% UpsideConsensus RatingHoldHoldHoldModerate Buy Forget Trump and Kamala (Ad)I hope you're deleting all those emails telling you how to make "1,000% gains" from the magic "Kamala Trade". It's nonsense. No one knows what's going to happen in November.THIS CALENDAR is the only thing that matters for you and your financial health right now. AVRO Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History AVRO Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table AVROBIO Stock vs. The CompetitionTypeAVROBIOMedical CompaniesS&P 500Consensus Rating Score 2.00 2.78 2.50Consensus RatingHoldModerate BuyHoldPredicted Upside1,614.29% Upside818.42% Upside6.14% UpsideNews Sentiment RatingNeutral NewsSee Recent AVRO NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails12/18/2023Mizuho2 of 5 stars DowngradeBuy ➝ Neutral$60.00 ➝ $24.00+47.06%7/13/2023Wells Fargo & Company3 of 5 stars Lower Target$30.00 ➝ $24.00+39.86%7/12/2023Wedbush3 of 5 starsD. NierengartenSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Neutral3/24/2023Needham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingBuy$72.00+574.16%12/7/2022BTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy rating UpgradeNeutral ➝ Buy$48.00+411.77%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 04:19 AM ET. AVRO Forecast - Frequently Asked Questions What is AVROBIO's forecast for 2024? According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for AVROBIO is $24.00, with a high forecast of $24.00 and a low forecast of $24.00. Should I buy or sell AVROBIO stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AVROBIO in the last year. There is currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AVRO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AVRO, but not buy additional shares or sell existing shares. Does AVROBIO's stock price have much upside? According to analysts, AVROBIO's stock has a predicted upside of 1,614.29% based on their 12-month stock forecasts. Do Wall Street analysts like AVROBIO more than its competitors? Analysts like AVROBIO less than other "medical" companies. The consensus rating for AVROBIO is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how AVRO compares to other companies. Stock Forecasts and Research Tools Related Companies: Compass Therapeutics Stock Forecast Genfit Stock Forecast Candel Therapeutics Stock Forecast Cabaletta Bio Stock Forecast Opthea Stock Forecast Caribou Biosciences Stock Forecast Scilex Stock Forecast Molecular Partners Stock Forecast Innate Pharma Stock Forecast Sangamo Therapeutics Stock Forecast Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools: Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Forget Trump and Kamala (Ad)I hope you're deleting all those emails telling you how to make "1,000% gains" from the magic "Kamala Trade". It's nonsense. No one knows what's going to happen in November.THIS CALENDAR is the only thing that matters for you and your financial health right now. This page (NASDAQ:AVRO) was last updated on 9/28/2024 by MarketBeat.com Staff From Our PartnersFed Triggers Boom: Buy this Play on Elon’s New AIHave you seen Elon Musk's new invention? I was already very bullish on this new type of AI. And now that...InvestorPlace | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | Sponsored10X More Profitable Than Physical Gold?The smart money is piling into gold and gold stocks. There's a backdoor gold play that could deliver 10 TIM...Monument Traders Alliance | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the ...Porter & Company | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored50-Yr Wall Street Legend: “Sell this AI stock NOW”Nearly 1 million people around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly ...Chaikin Analytics | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVROBIO, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVROBIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVRO Stock Alerts